Silence Therapeutics (SLNCF) Other Working Capital Changes (2020 - 2025)
Historic Other Working Capital Changes for Silence Therapeutics (SLNCF) over the last 6 years, with Q3 2025 value amounting to -$5.3 million.
- Silence Therapeutics' Other Working Capital Changes fell 156013.45% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.9 million, marking a year-over-year decrease of 52845.95%. This contributed to the annual value of $457998.0 for FY2024, which is 10443.67% up from last year.
- Per Silence Therapeutics' latest filing, its Other Working Capital Changes stood at -$5.3 million for Q3 2025, which was down 156013.45% from -$3.0 million recorded in Q2 2025.
- Silence Therapeutics' Other Working Capital Changes' 5-year high stood at $2.7 million during Q4 2023, with a 5-year trough of -$24.2 million in Q4 2024.
- Its 5-year average for Other Working Capital Changes is -$2.4 million, with a median of -$920499.3 in 2022.
- As far as peak fluctuations go, Silence Therapeutics' Other Working Capital Changes surged by 28716.81% in 2023, and later tumbled by 156013.45% in 2025.
- Quarter analysis of 5 years shows Silence Therapeutics' Other Working Capital Changes stood at -$3.6 million in 2021, then surged by 119.72% to $701411.1 in 2022, then soared by 287.17% to $2.7 million in 2023, then tumbled by 989.66% to -$24.2 million in 2024, then soared by 77.93% to -$5.3 million in 2025.
- Its last three reported values are -$5.3 million in Q3 2025, -$3.0 million for Q2 2025, and $592000.0 during Q1 2025.